Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia
paradigm_report_works_22122023
10.1111_jnc.13997
39
4
2017
614
625
article
141
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13997
Journal of Neurochemistry
Wiley
Andreas Dammann Andersen
Morten Blaabjerg
Michael Binzer
Akram Kamal
Helle Thagesen
Troels W. Kjær
Egon Stenager
Jan Bert Gramsbergen
True
10.1111/jnc.13997
Cerebrospinal fluid levels of catecholamines and its metabolites in Parkinson's disease: effect of l‐DOPA treatment and changes in levodopa‐induced dyskinesia
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our
Terms of Service and Privacy Policy.